Unknown

Dataset Information

0

Deglycosylation of eukaryotic-expressed flagellin restores adjuvanticity.


ABSTRACT: Flagellin, the TLR5 agonist, shows potent adjuvant activities in diverse vaccines and immunotherapies. Vibrio vulnificus flagellin B expressed in eukaryotic cells (eFlaB) could not stimulate TLR5 signaling. Enzymatic deglycosylation restored eFlaB's TLR5 stimulating functionality, suggesting that glycosylation interferes with eFlaB binding to TLR5. Site-directed mutagenesis of N-glycosylation residues restored TLR5 stimulation and adjuvanticity. Collectively, deglycosylated eFlaB may provide a built-in adjuvant platform for eukaryotic-expressed antigens and nucleic acid vaccines.

SUBMITTER: Khim K 

PROVIDER: S-EPMC10522637 | biostudies-literature | 2023 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Deglycosylation of eukaryotic-expressed flagellin restores adjuvanticity.

Khim Koemchhoy K   Puth Sao S   Radhakrishnan Kamalakannan K   Nguyen Tien Duc TD   Lee Youn Suhk YS   Jung Che-Hun CH   Lee Shee Eun SE   Rhee Joon Haeng JH  

NPJ vaccines 20230926 1


Flagellin, the TLR5 agonist, shows potent adjuvant activities in diverse vaccines and immunotherapies. Vibrio vulnificus flagellin B expressed in eukaryotic cells (eFlaB) could not stimulate TLR5 signaling. Enzymatic deglycosylation restored eFlaB's TLR5 stimulating functionality, suggesting that glycosylation interferes with eFlaB binding to TLR5. Site-directed mutagenesis of N-glycosylation residues restored TLR5 stimulation and adjuvanticity. Collectively, deglycosylated eFlaB may provide a b  ...[more]

Similar Datasets

2019-04-15 | PXD010461 | Pride
| S-EPMC4579647 | biostudies-literature
| S-EPMC3946582 | biostudies-literature
| PRJEB47543 | ENA
| S-EPMC4152760 | biostudies-literature
| S-EPMC3979859 | biostudies-literature
| S-EPMC7302928 | biostudies-literature
| S-EPMC8832471 | biostudies-literature
| S-EPMC10411910 | biostudies-literature
| S-EPMC10028819 | biostudies-literature